Edit search
111In-bevacizumab imaging of renal cell cancer and evaluatio…
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.
Article, Chapter
Authors: I.M.E. Desar
Publication: Volume:51, Issue:11, Page(s):1707-1715
Published: 2010
Browse related articles
  Request a copy of this item
Cite this item